![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, October 24, 2015 6:32:59 PM
Those are weekly numbers. In other words there were 11,254 total prescriptions filled that week. Of that number 10,457 were for Coxpone from Teva and 797 for Glatopia from Sandoz.
We can further break down for that week and say 2699 patients received new prescriptions from their doctor for Teva's Copaxone and 252 patients received new prescriptions for Glatopia.
Breaking it down one more step we can say that 2699 patients received new scripts for Copaxone while 7758 patients just got their monthly refill. Also 252 patients got new Glatopia scripts while 545 patients just got a refill.
We can't separate the daily Copaxone from the 3X Copaxone but we can guess somewhere in the low 70% would be about right.
If you have followed this link for awhile you'll notice that Glatopia is stuck in the mud. It's either that patients aren't being prescribed or there's a almost equal amount of patients dropping off as there are new patients.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM